Inventor · disambiguated record
Ephraim Joseph Fuchs
Also filed as: FUCHS EPHRAIM · FUCHS EPHRAIM J · FUCHS EPHRAIM JOSEPH
3 granted patents·10 pending applications·1 citations·filing 2011–2025
52Inventor score
Top patents by PatentIndex Score
13 records- 0174US2025304910A1Methods and compositions for infusion of transiently engrafting, selected populations of allogeneic lymphocytes to treat cancerUNIV JOHNS HOPKINS·Filed 2025·Application pending·0 cites
- 0268US12359167B2Methods and compositions for infusion of transiently engrafting, selected populations of allogeneic lymphocytes to treat cancerUNIV JOHNS HOPKINS·Filed 2021·Granted Jul 15, 2025·0 cites·8 claims
- 0363US9931359B2Methods and compositions for infusion of transiently engrafting, selected populations of allogeneic lymphocytes to treat cancerUNIV JOHNS HOPKINS·Filed 2013·Granted Apr 3, 2018·1 cites·15 claims
- 0455US2021139418A1Personalized, allogeneic cell therapy of cancerUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 0555US2024390493A1Methods and compositions to augment efficacy and reduce toxicity of non-engrafting, cd8-depleted allogenic donor lymphocyte infusionsUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 0653US2018265456A1Personalized, allogeneic cell therapy of cancerUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 0750US2018280439A1Methods and compositions for infusion of transiently engrafting, selected populations of allogeneic lymphocytes to treat cancerUNIV JOHNS HOPKINS·Filed 2018·Application pending·0 cites
- 0846US2024422818A1Communication devices and methods for bidirectional transmit opportunitiesSONY GROUP CORP·Filed 2022·Application pending·0 cites
- 0946US2023172941A1Prophylaxis and treatment of pathogenic coronavirus infectionsUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 1045US2023100653A1Cancer immunotherapy using transfusions of allogeneic, tumor-specific cd4+ t cellsUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 1143US12188004B2Cancer immunotherapy using transfusions of allogeneic, tumor-specific CD4+ T cellsUNIV JOHNS HOPKINS·Filed 2020·Granted Jan 7, 2025·0 cites·19 claims
- 1240US2013302409A1Methods and compositions for cancer immunotherapyFUCHS EPHRAIM JOSEPH·Filed 2011·Application pending·0 cites
- 1340US2012148577A1Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejectionFUCHS EPHRAIM J·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ephraim Joseph Fuchs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →